Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss requirements with the expert in detail before accepting statement of work from Kolabtree
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but approve the deliverables only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 50 /hr
Hire Dr. Sandhya B.
United States
USD 50 /hr

Transplant immunologist with research experience in molecular biology, microbiology, biochemistry and drug discovery.

Profile Summary
Subject Matter Expertise
Writing Clinical Trial Documentation, Technical Writing, Copywriting, Newswriting
Research Market Research, User Research, Meta-Research, Feasibility Study, Fact Checking, Gap Analysis, Gray Literature Search, Systematic Literature Review, Secondary Data Collection
Consulting Digital Strategy Consulting, Scientific and Technical Consulting, Regulatory Consulting
Data & AI Statistical Analysis, Data Visualization, Big Data Analytics, Data Processing, Data Insights
Product Development Formulation, Stability/Shelf Life Testing, Product Evaluation, Material Sourcing, Product Validation, Manufacturing, Concept Development, Prototyping
Work Experience

Dignity Health

July 2016 - Present

Postdoctoral Fellow

University of Illinois at Urbana Champaign

July 2015 - July 2016

Postdoctoral fellow

Regional Centre for Biotechnology

April 2012 - June 2015



Dr. B.R Ambedkar Center for Biomedical Research

July 2005 - July 2012


Dr B R Ambedkar center for Biomedical Research

July 2003 - June 2005

B.Sc , Biochemistry

Kurukshetra University

June 2000 - June 2003

  • Certification details not provided.
(2019). A novel mechanism for immune regulation after human lung transplantation . The Journal of Thoracic and Cardiovascular Surgery.
(2019). Benzimidazoles: Selective inhibitors of Topoisomerase I with Differential mode of action. Biochemistry.
(2018). The Role of Exosomes in Allograft Immunity. Cellular immunology.
(2018). Bisphosphonate-Generated ATP-Analogs Inhibit Cell Signaling Pathways. J Am Chem Soc.
(2018). Tissue-associated self-antigens containing exosomes: Role in allograft rejection. Hum Immunol.
(2017). Pulsed Electron Paramagnetic Resonance Insights into the Ligand Environment of Copper in Drosophila Lysyl Oxidase. Biochemistry.
(2017). Topoisomerases Resistance vs Sensitivity: How far we can go?. Med Res Rev.
(2017). Deciphering the Role of Hydrophobic and Hydrophilic Bile Acids in Angiogenesis using in vitro and in vivo Model Systems. Med Chem Comm.
(2016). Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation.
(2015). Nature of the charged head group dictates the anticancer potential of Lithocholic acid-Tamoxifen conjugates for breast cancer therapy. Med. Chem. Commun.
(2015). Cell-penetrating Synthetic Antimicrobial Polypeptides (SAMPs) exhibiting potent and selective killing of Mycobacterium by targeting its DNA. Chemistry: A Europeon Journal. 2015; 21(9):3540-5.
(2015). Nature of the charged head group dictates the anticancer potential of Lithocholic acid-Tamoxifen conjugates for breast cancer therapy. Med. Chem. Commun 2015, 6, 778-787.
(2015). Synthesis, structure–activity relationship, and mechanistic investigation of lithocholic acid amphiphiles for colon cancer therapy. Med. Chem. Commun., 2015, 6, 192-201.
(2014). Bile acid amphiphiles with tunable head groups as highly selective antitubercular agents. Med. Chem. Commun., 2014, 5, 1761-1768.
(2013). Design, synthesis, and mechanistic investigations of Bile acid-Tamoxifen conjugates for Breast cancer therapy. Bioconjug Chem. 18, 2013; 24(9):1468-84.
(2013). Deciphering the role of charge, hydration, and hydrophobicity for cytotoxic activities and membrane interactions of bile acid based facial amphiphiles. Biophys. Biochim. Acta Biomembranes, (2013) 1828(8):1926-37.
(2012). 3, 4 dimethoxyphenyl bisbenzimidazole, a novel DNA Topoisomerase inhibitor that preferentially targets type IA Topoisomerase. Journal of Antimicrobial Chemotherapy, (2012) 67(12): 2882-2891.
(2011). Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates. International Journal of Antimicrobial Agents 37 (2011) 253-255.
(2010). Old class but new dimethoxy analogue of benzimidazole: a bacterial topoisomerase I inhibitor. International Journal of Antimicrobial Agents 35 (2010) 186-190.
(2007). Nuclear condensation and free radical scavenging: A dual mechanism of Bisbenzimidazoles to modulate radiation damage to DNA. Mol. Cell. Biochem. (2007) 305: 221-233.
(2006). Synthesis and in vitro cytotoxicity of haloderivatives of noscapine. Bioorganic & Medicinal Chemistry, 2006, Oct 1; 14(19): 6733-6.